Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN Study

Rizk, DV; Rovin, BH; Zhang, H; Kashihara, N; Maes, B; Trimarchi, H; Perkovic, V; Meier, M; Kollins, D; Papachristofi, O; Charney, A; Barratt, J

Rizk, DV (通讯作者),Univ Alabama Birmingham, Div Nephrol, Dept Med, 1720 2nd Ave S,ZRB 614, Birmingham, AL 35294 USA.

KIDNEY INTERNATIONAL REPORTS, 2023; 8 (5): 968

Abstract

Introduction: Targeting the alternative complement pathway (AP) is an attractive therapeutic strategy because of its role in immunoglobulin A nephropa......

Full Text Link